win 57273 has been researched along with gentamicin in 2 studies
| Studies (win 57273) | Trials (win 57273) | Recent Studies (post-2010) (win 57273) | Studies (gentamicin) | Trials (gentamicin) | Recent Studies (post-2010) (gentamicin) |
|---|---|---|---|---|---|
| 23 | 0 | 0 | 19,191 | 1,365 | 3,650 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, MS; Erwin, ME; Jones, RN; Koontz, FP | 1 |
| Mehl, P; Noskin, GA; Warren, JR | 1 |
2 other study(ies) available for win 57273 and gentamicin
| Article | Year |
|---|---|
CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium chelonae; Nontuberculous Mycobacteria; Quinolones | 1992 |
Bactericidal activity of the fluoroquinolone WIN 57273 against high-level gentamicin-resistant Enterococcus faecalis.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Quinolones; Time Factors | 1993 |